Health Care [ 3/12 ] | Health Care Technology [ 15/74 ]
NASDAQ | Common Stock
GeneDx Holdings Corp., a genomics company, provides personalized and actionable health insights to inform diagnosis, direct treatment, and improve drug discovery.
The company accelerate the use of genomics and leverage clinical data to enable precision medicine as the standard of care.
It utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process DNA-containing samples, analyzes information about patient-specific genetic variation, and generates test reports for clinicians and their patients.
The company offers genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening.
GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 53.30 M Decreased by -35.96% | -42.29 M Increased by +45.49% | Decreased by -79.33% Increased by +14.89% |
| Jun 30, 23 | 48.71 M Increased by +34.66% | -46.72 M Increased by +45.51% | Decreased by -95.92% Increased by +59.54% |
| Mar 31, 23 | 43.14 M Decreased by -20.03% | -60.99 M Increased by +5.42% | Decreased by -141.38% Decreased by -18.26% |
| Dec 31, 22 | 61.35 M Increased by +6.14% | -308.76 M Decreased by -668.35% | Decreased by -503.28% Decreased by -623.90% |
| Sep 30, 22 | 83.23 M Increased by +92.77% | -77.58 M Decreased by -347.14% | Decreased by -93.21% Decreased by -228.20% |
| Jun 30, 22 | 36.17 M Decreased by -22.82% | -85.74 M Decreased by -89.02% | Decreased by -237.06% Decreased by -144.91% |
| Mar 31, 22 | 53.94 M Decreased by -15.98% | -64.49 M Increased by +66.37% | Decreased by -119.55% Increased by +59.98% |
| Dec 31, 21 | 57.80 M Decreased by -9.63% | -40.19 M Increased by +68.03% | Decreased by -69.52% Increased by +64.62% |